LB Pharmaceuticals Inc (NASDAQ:LBRX) Appoints Susan G. Kozauer, M.D. as CMO
LB Pharmaceuticals Inc named Susan G. Kozauer, M.D. as Chief Medical Officer. The company highlighted her late-stage neuropsychiatric drug development experience ahead of its Phase 3 NOVA-2 schizophrenia readout expected in H1 2027.Material DetailsContext by AI AnalystThis is an early-to-mid cycle…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.